Tech Company Financing Transactions
Relmada Therapeutics Funding Round
Relmada Therapeutics closed a $3 million Series A funding round on 7/25/2012. Investors included Ben Franklin Technology Partners, Laidlaw & Company and private investors.
Transaction Overview
Company Name
Announced On
7/25/2012
Transaction Type
Venture Equity
Amount
$3,000,000
Round
Series A
Proceeds Purpose
The initial Series A proceeds will be used to continue the development of LevoCap, a proprietary once-a-day extended release dosage form of the potent opioid levorphanol in a tamper resistant delivery system and for general corporate activities.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
880 3rd Ave. 12th Floor
New York, NY 10022
USA
New York, NY 10022
USA
Phone
Website
Email Address
Overview
Relmada is a clinical stage pain management company with a diversified portfolio of products for the treatment of chronic pain.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Sergio Traversa
Chief Medical Officer
Ottavio Vitolo
VP - Operations
Gina DiGuglielmo
Browse more venture capital transactions:
Prev: 7/25/2012: Xamarin venture capital transaction
Next: 7/25/2012: Chute venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs